The present invention provides a method of manufacturing a three-dimensional product having uniform mechanical properties using an SLS 3D printer including the steps of: preparing a mixed powder material by mixing resin powder and glass bubbles, wherein the specific gravity of the glass bubbles is from about 0.8 to about 1.2 times that of the resin powder; supplying the mixed powder material to the 3D printer using a roller; and selectively sintering the mixed powder material by irradiating the powder material using a laser based on 3D data of the product to be manufactured.

A preparation method for a metal matrix composite wire includes the following steps: 1) preparing a metal inner core; 2) preparing a glass-resin mixture; 3) dissolving self-adhesive resin in a solvent to prepare a self-adhesive resin solution; 4) uniformly coating the glass-resin mixture on a surface of the metal inner core, then coating the self-adhesive resin solution on a surface of the glass-resin mixture, and performing drying at a temperature of 80 C. to 150 C.; and 5) repeating the step 4) until a thickness of the glass-resin mixture plus the self-adhesive resin reaches 2 to 10 m. When an inductor is prepared by using the composite wire, the inductor may have relatively good weather resistance, a relatively good dielectric voltage-withstand capability, as well as relatively good high-temperature resistance and electrical performance.

A glass pharmaceutical package having a glass composition of 68.00 mol % to 81.00 mol % SiO.sub.2, from 4.00 mol % to 11.00 mol % Al.sub.2O.sub.3, from 0.10 mol % to 16.00 mol % Li.sub.2O, from 0.10 mol % to 12.00 mol % Na.sub.2O, from 0.00 mol % to 5.00 mol % K.sub.2O, from 0.10 mol % to 8.00 mol % MgO, from 0.10 mol % to 5.00 mol % CaO, from 0.00 mol % to 0.20 mol % fining agent. The glass pharmaceutical package is delamination resistant, and has class 1 or class 2 chemical durability in acid, base, and water. The glass pharmaceutical package may have a surface compressive stress of at least 350 MPa.

The invention relates to the technical field of artificial stone surfaces, in particular to an artificial glass surface, which is made from the following raw materials in parts by mass: 0-30 parts of a quartz material, 40-70 parts of a glass material, 5-15 parts of a modified silicone resin, 8-15 parts of an unsaturated polyester resin, and 5-14 parts of additional raw materials. The artificial glass surface employs recycled glass material as its main stone source, which contributes the conservation of mineral resources, and reduces production costs; the product is of higher quality.

A glass pharmaceutical package having a glass composition of 68.00 mol % to 81.00 mol % SiO.sub.2, from 4.00 mol % to 11.00 mol % Al.sub.2O.sub.3, from 0.10 mol % to 16.00 mol % Li.sub.2O, from 0.10 mol % to 12.00 mol % Na.sub.2O, from 0.00 mol % to 5.00 mol % K.sub.2O, from 0.10 mol % to 8.00 mol % MgO, from 0.10 mol % to 5.00 mol % CaO, from 0.00 mol % to 0.20 mol % fining agent. The glass pharmaceutical package is delamination resistant, and has class 1 or class 2 chemical durability in acid, base, and water. The glass pharmaceutical package may be substantially free of B.sub.2O.sub.3, SrO, BaO, and ZrO.sub.2.

A fining agent for reducing the concentration of seeds or bubbles in a silicate glass. The fining agent includes at least one inorganic compound, such as a hydrate or a hydroxide that acts as a source of water. In one embodiment, the fining agent further includes at least one multivalent metal oxide and, optionally, an oxidizer. A fusion formable and ion exchangeable silicate glass having a seed concentration of less than about 1 seed/cm.sup.3 is also provided. Methods of reducing the seed concentration of a silicate glass, and a method of making a silicate glass having a seed concentration of less than about 1 seed/cm.sup.3 are also described.

The invention relates to the technical field of artificial stone surfaces, in particular to an artificial glass surface, which is made from the following raw materials in parts by mass: 0-30 parts of a quartz material, 40-70 parts of a glass material, 5-15 parts of a modified silicone resin, 8-15 parts of an unsaturated polyester resin, and 5-14 parts of additional raw materials. The artificial glass surface employs recycled glass material as its main stone source, which contributes the conservation of mineral resources, and reduces production costs; the product is of higher quality.

The invention relates to a fiber reinforced thermoplastic molding composition comprising a thermoplastic polymer and reinforcing fibers, wherein the composition comprises (i) a thermoplastic polymer selected from the group consisting of polyesters, polyamides, polycarbonates, polyphenylene sulphides (PPS), polyphenylene ethers (PPO), polyetheretherketones (PEEK), polyaryletherketones (PAEK), polyamidimides (PAI), polyetherimides (PEI) and liquid crystal polymers (LCPs), and combinations thereof and (ii) silicon-boron glass fibers consisting predominantly of silicon dioxide (SiO.sub.2) and boron trioxide (B.sub.2O.sub.3).

A method of manufacturing a resorbable, macroporous bioactive glass scaffold comprising approximately 15-45% CaO, 30-70% SiO.sub.2, 0-25% Na.sub.2O, 0-17% P.sub.2O.sub.5, 0-10% MgO and 0-5% CaF.sub.2 by mass percent, produced by mixing with pore forming agents and specified heat treatments.

A composition for a FDM 3D printer is disclosed. The composition contains bioglass and a biocompatible polymer resin. In addition, a FDM 3D printer molded article having a laminated strut structure, in which the composition for the FDM 3D printer is injected into four layers, is disclosed.